Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DYNPORT VACCINE COMPANY LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-05-13 to 2025-01-31
Current total value of award: $4120677
Description: PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES